Lv2
130 积分 2026-02-26 加入
Ultralow-Dose Interleukin 10–Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
27天前
已完结
Ultralow-Dose Interleukin 10–Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
27天前
已完结
Novel format single-domain antibodies using human VL domain as scaffold
28天前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
1个月前
已完结
New insights into antibody structure with implications for specificity, variable region restriction and isotype choice
1个月前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
1个月前
已完结
The downstream purification of bispecific antibodies
1个月前
已完结
OpenIO: An open framework for AI-native immunotherapy
1个月前
已完结
Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease
2个月前
已完结
Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy
2个月前
已完结
皖公网安备34019202002308
